help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 20, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0068
Molecular Endocrinology Vol. 0, No. 2007 200700681-
doi:10.1210/me.2007-0068
Copyright © 2007 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
22/3/676    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peverelli, E.
Right arrow Articles by Spada, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peverelli, E.
Right arrow Articles by Spada, A.

Submitted on February 2, 2007
Accepted on December 10, 2007

The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation

Erika Peverelli, Giovanna Mantovani, Davide Calebiro, Andrea Doni, Sara Bondioni, Andrea Lania, Paolo Beck-Peccoz, and Anna Spada*

Endocrine Unit, Department of Medical Sciences, University of Milan, Fondazione Policlinico IRCCS, Milan; Istituto Auxologico Italiano IRCCS, Cusano Milanino, Milan; Istituto Clinico Humanitas (ICH), Department of Immunology and Inflammation, Rozzano, Milan 20089; Italy

* To whom correspondence should be addressed. E-mail: anna.spada{at}unimi.it.

Somatostatin (SS) is a widely distributed polypeptide that exerts inhibitory effects on hormone secretion and cell proliferation by interacting with five different receptors (SST1-SST5). Beta-arrestins have been implicated in regulating SST internalization but the structural domains mediating this effect are largely unknown. The aim of this study was to characterize the intracellular mechanisms responsible for internalization of human SST5 in the rat pituitary cell line GH3 and to identify the SST5 structural domains involved in this process. To this purpose we evaluated by fluorescence microscopy and biochemical assay the ability of wild-type, progressive C-terminal truncated and third cytoplasmatic loop mutants SST5-DsRed to associate with beta arrestin-EGFP and to internalize under SS28 stimulation. The truncated mutants were comparable to the wild-type receptor with respect to recruitment of beta arrestin-2 and internalization, whereas the third loop mutants R240W, S242A and T247A showed the abolishment or reduction of arrestin association and a significant reduction of receptor internalization (14.4%, 29% and 30.9% vs 52.4% of wild type) and serine phosphorylation upon SS28 stimulation. Moreover, we evaluated the ability of simultaneous mutation of these three residues (RST) and C-terminal truncated receptors to internalize. The progressive truncation of C-terminal tail resulted in a progressive increased internalization (21.6%, 36.7% and 41%, respectively) with respect to full-length RST mutant (15%). In conclusion, our results indicate the SST5 third intracellular loop as an important mediator of beta arrestin/receptor interaction and receptor internalization, while they suggest that residues 328–347 within the C-terminus may play an inhibitory role in receptor internalization.


Key words: human SST5 • 3rd intracellular loop • arrestin • internalization







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society